Merck Offloads Allergy Business to Dermapharm

GALWAY, IRELAND--March 10, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German drugmaker Merck KGaA is offloading its Allergopharma allergy business to Dermapharm, a leading manufacturer of off-patent branded medicines for selected markets in Germany.

Within this article: Details sale of Merck allergy business Allergopharma, refocus of Merck on biosimilars